Articles Tagged With:
-
Give People What They Need in Informed Consent: Plain Language
Most research informed consent forms are written at a high school reading level when many people who are being recruited for studies might need language nearer to a fifth-grade level, according to a new study.
-
Dissenting Opinion: New Common Rule Penalizes the Compliant
Many see the single IRB requirement in the revised Common Rule as a necessary sword to sever the Gordian knot of regulatory overlap and unnecessary delay of multisite review. Suzanne M. Rivera, PhD, is not one of them.
-
Deadline Extended for Common Rule Compliance
With finalization of the revised Common Rule postponed for at least six months — and possibly one year — IRBs should continue preparing to comply with the regulation as they await additional clarification and guidance.
-
Antivaccine Attitudes: The Truth Is Out There
In a fascinating study of the roots of psychological attitudes, researchers report that people who are against vaccinations are more likely to believe in conspiracy theories.
-
The High Cost of C. diff Infection and Relapse
Clostridium difficile claims a staggering toll in patient infections annually, and a new study estimates the cost of treatment is nearly $25,000 based on five days of hospitalization. Recurrent infections, not an uncommon phenomenon with C. diff, add an additional two days and another $10,500.
-
Joint Commission Dings Hand Hygiene Lapses
Infection preventionists should be aware that as part of its ongoing enforcement of patient safety goals, The Joint Commission will be assessing hand hygiene compliance during 2018 accreditation surveys.
-
Mind the Gap: SHEA Guidance on Ending Isolation
While there is a dearth of data to make completely informed decisions on aspects of this issue, the Society for Healthcare Epidemiology of America (SHEA) has issued a guidance document that hospitals can use as a framework for making policy.
-
APIC-SHEA Forming Formidable Partnership
The two major infection control associations in the United States are forging a forward-thinking partnership. It includes several major initiatives that will be enacted this year, with efforts underway to bring in patient and consumer advocates and collaborate in presentations and published papers.
-
A Call to Action to Prevent Non-vent Pneumonia
What if there were a routine addition to patient care that could save some 10,000 lives annually? An increasing body of research says there is.
-
Flu Vaccine Efficacy Poor as H3N2 Outbreak Surges
With the nation reeling from an historically bad influenza outbreak, the Centers for Disease Control and Prevention is preparing the public for a dismal efficacy estimate for the 2017-18 vaccine against the predominant H3N2 A flu strain.